ARK Genomic Revolution ETF (BATS:ARKG) Shares Cross Above Fifty Day Moving Average – Time to Sell?

ARK Genomic Revolution ETF (BATS:ARKG)’s share price passed above its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $49.46 and traded as high as $51.99. ARK Genomic Revolution ETF shares last traded at $51.65, with a volume of 6,004,095 shares.

ARK Genomic Revolution ETF Trading Up 0.5%

The company’s 50-day simple moving average is $49.84 and its 200 day simple moving average is $37.27.

Institutional Investors Weigh In On ARK Genomic Revolution ETF

Hedge funds and other institutional investors have recently bought and sold shares of the company. Canal Insurance CO acquired a new position in ARK Genomic Revolution ETF during the 3rd quarter valued at approximately $6,517,000. Gimbal Financial acquired a new stake in shares of ARK Genomic Revolution ETF during the third quarter worth $6,478,000. Baird Financial Group Inc. lifted its stake in shares of ARK Genomic Revolution ETF by 0.3% during the second quarter. Baird Financial Group Inc. now owns 73,722 shares of the company’s stock worth $3,101,000 after buying an additional 255 shares during the period. D.A. Davidson & CO. purchased a new stake in shares of ARK Genomic Revolution ETF during the third quarter valued at $3,000,000. Finally, Client First Investment Management LLC purchased a new stake in shares of ARK Genomic Revolution ETF during the second quarter valued at $2,579,000.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.